NCT04626427View on ClinicalTrials.gov

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation

NATerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
End Stage Kidney DiseaseChronic Kidney DiseasesKidney FailureKidney InsufficiencyKidney Disease, ChronicAV FistulaFistulas Arteriovenous
Interventions
DEVICE

WavelinQ™ EndoAVF System

AVF endovascular creations using the WavelinQ™ EndoAVF System

Trial Locations (3)

2820

Imelda Hospital Bonheiden, Bonheiden

8401

Kantonsspital Winterthur, Winterthur

26504

"University Hospital of Patras Panagia I Voitheia", Rio

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT04626427 - The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation | Biotech Hunter | Biotech Hunter